Top of page Skip navigation

'Maximising Returns from Life Science Innovation'

Whether addressing global health challenges, sustainability, economics, or inclusion & equality, there has perhaps never been such collective drive and desire to ensure all stakeholders can participate in, and derive benefit from, scientific and business innovation.

The 2022 Keynote Programme at Genesis will explore how innovation in Life Sciences is leading to inclusive stakeholder rewards.

Tuesday 6 December 2022 - Genesis Eve Networking Drinks

See 'Fringe Events' for more information

Wednesday 7 December 2022 - Keynote Programme

08.30 Registration
09.00 Welcome from One Nucleus
  Jon Green, One Nucleus
 09.10 Keynote Address: Winners & Losers 2022
  Mike Ward, Clarivate
 09.30 Panel: Innovative Dealmaking for Innovative Solutions
  A discussion to review the latest trends in life science investment and partnering deals, what have previous financing cycles taught us? 

Moderator: Amy Brown, Evaluate Vantage

Panelists: Julie Simmonds, Panmure GordonJames Fry, Mills & ReeveWill Walker-Arnott, Charles Stanley Wealth ManagementKate Rowley, Global Bio Fund, Jérôme Van Biervliet, VIB

10.30 Coffee Break
11.00 www.LifeSciences.2023
  Who will be the stakeholders shaping and disrupting the sector in 2023 and beyond?
What – technologies, in R&D, drug delivery or related field will provide the best solutions for patients?
When will we see the impacts of the above take effect?

Moderator: Paul Branthwaite, tranScrip

Panelists: Laura Lane, Eli Lilly, David Roblin, Relation Therapeutics, Miguel Forte, AdBio Partners, Cristina Oliva, BerGenBio  

11.50 Pre-Lunch Debate: This House Believes: 

“The Golden Triangle is a Better Ecosystem to Grow a Life Science Company Than Greater Boston”

Following the One Nucleus trade visit to Boston in September 2022, the delegation will feedback their views on what they discovered when comparing these two key life science clusters. The debate will close with an audience vote in favour or in opposition to the title statement


PresidingMike Ward, Clarivate 

Debaters: Catherine Stace, Domainex, Max Bryan, Bidwells, John McCafferty, Maxion Therapeutics, Nick Foster, Metrion Biosciences, Jiahao Huang, Nuclera

12.30 Lunch
13.30 Panel: Is Technology Diversifying Biomedical R&D Outputs?

The ability to generate, collect and analyse data from diverse sources has never advanced more rapidly. The panel will discuss whether this is leading to greater diversity in areas such as, target selection & drug design, patient stratification in clinical trials, scale of collaboration and skills


Moderator: Lisa Melton, Nature Biotechnology

Panelists: Rowan Gardner, PrecisionLife, Andy Richards, Ieso Digital Health, Victor Neduva, MSD, Krzysztof Potempa, Braincures

 14.20  Panel: Value Creation and Sharing in a Converging World
   As R&D evolves to include ever-increasing reliance on Big Data/AI, external partnerships and global markets, how do we collaborate to protect, capture and share the created value equitably?

Moderator: Victoria English, MedNous

Panelists: Hannah Sore, PharmEnable, Chris Wayman, EY, Claire Smith, Bristows, Bradley Hardiman, Astellas Pharma, Peter Peumans, imec

15.00 Coffee Break
15.30 So, what do you think?

A chance to listen in to a conversation you wish you had heard as two leading lights share their thoughts on a key question facing the life science sector right now

'Are Diamonds Better Than Gold?’
Claire Thompson, CEO, Agility Life Sciences and Miranda Knaggs, Corporate Development Director, We Are Pioneer Group discussing how the reshaping UK Life Sciences sector could think outside the triangle

15.50 Panel: The Anatomy of a Life Science Leader

The panel will discuss what successful traits of leadership are required to build an innovation-led life science company


Moderator: Mike Ward, Clarivate

Panelists: Suzanne Holden, Thermo Fisher, Anji Miller, LifeArc, Barry Winkless, Cpl Future of Work Institute, Lisa Page, Penningtons Manches Cooper

16.50 Presentation BioNewsRound Awards
  Followed by
  Closing Remarks

Tony Jones, One Nucleus

17.00 Drinks Reception
18.00 Close